Sammamish, WA – According to filings with the U.S. Securities and Exchange Commission, Cadence Neuroscience is raising $15 Million in a new round of investment. Sources indicate as part of senior management President and Chief Executive Officer, Kent Leyde played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Cadence Neuroscience

adence Neuroscience is an early-stage company developing new medical device therapies for the treatment of epilepsy, central pain, and other neurological disorders.  Our core technology has been developed at Mayo Clinic and is under clinical evaluation.

To learn more about Cadence Neuroscience, visit http://www.cadenceneuro.com/

Contact:
Kent Leyde, President and Chief Executive Officer
425-681-6863
https://www.linkedin.com/in/kent-leyde-2342a45/

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved